Cargando…

Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations

The present research had been attempted to formulate and characterize tocotrienols-rich naringenin nanoemulgel for topical application in chronic wound conditions associated with diabetes. In due course, different phases of the nanoemulsion were chosen based on the solubility study, where combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Eileen, Yew Chieng, Clement Jia, Choudhury, Hira, Pandey, Manisha, Gorain, Bapi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663980/
https://www.ncbi.nlm.nih.gov/pubmed/34909654
http://dx.doi.org/10.1016/j.crphar.2021.100019
_version_ 1784613758890409984
author Yeo, Eileen
Yew Chieng, Clement Jia
Choudhury, Hira
Pandey, Manisha
Gorain, Bapi
author_facet Yeo, Eileen
Yew Chieng, Clement Jia
Choudhury, Hira
Pandey, Manisha
Gorain, Bapi
author_sort Yeo, Eileen
collection PubMed
description The present research had been attempted to formulate and characterize tocotrienols-rich naringenin nanoemulgel for topical application in chronic wound conditions associated with diabetes. In due course, different phases of the nanoemulsion were chosen based on the solubility study, where combination of Capryol 90 and tocotrienols, Solutol HS15, and Transcutol P were selected as oil, surfactant, and cosurfactant, respectively. The nanoemulsions were formulated using the spontaneous emulsification method. Subsequently, Carbopols were incorporated to develop corresponding nanoemulgels of the optimized nanoemulsions. Thermodynamically stable optimized nanoemulgels were evaluated for their globule size, polydispersity index (PDI), surface charge, viscosity, mucoadhesive property, spreadability, in vitro release and release mechanism. Further, increasing polymer concentration in the nanoemulgels was reflected with the increased mucoadhesive property with corresponding decrease in the release rate of the drug. The optimized nanoemulgel (NG1) consisted of uniform dispersion (PDI, 0.452 ​± ​0.03) of the nanometric globules (145.58 ​± ​12.5) of the dispersed phase, and negative surface charge (−21.1 ​± ​3.32 ​mV) with viscosity 297,600 ​cP and good spreadability. In vitro release of naringenin in phosphate buffer saline revealed a sustained release profile up to a maximum of 74.62 ​± ​4.54% from the formulated nanoemulgel (NG1) within the time-frame of 24 ​h. Alternatively, the release from the nanoemulsion was much higher (89.17 ​± ​2.87%), which might be due to lack of polymer coating on the dispersed oil droplets. Moreover, the in vitro release kinetics from the nanoemulgel followed the first-order release and Higuchi model with non-Fickian diffusion. Therefore, encouraging results in this research is evident in bringing a promising future in wound management, particularly associated with diabetes complications.
format Online
Article
Text
id pubmed-8663980
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86639802021-12-13 Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations Yeo, Eileen Yew Chieng, Clement Jia Choudhury, Hira Pandey, Manisha Gorain, Bapi Curr Res Pharmacol Drug Discov Research Paper The present research had been attempted to formulate and characterize tocotrienols-rich naringenin nanoemulgel for topical application in chronic wound conditions associated with diabetes. In due course, different phases of the nanoemulsion were chosen based on the solubility study, where combination of Capryol 90 and tocotrienols, Solutol HS15, and Transcutol P were selected as oil, surfactant, and cosurfactant, respectively. The nanoemulsions were formulated using the spontaneous emulsification method. Subsequently, Carbopols were incorporated to develop corresponding nanoemulgels of the optimized nanoemulsions. Thermodynamically stable optimized nanoemulgels were evaluated for their globule size, polydispersity index (PDI), surface charge, viscosity, mucoadhesive property, spreadability, in vitro release and release mechanism. Further, increasing polymer concentration in the nanoemulgels was reflected with the increased mucoadhesive property with corresponding decrease in the release rate of the drug. The optimized nanoemulgel (NG1) consisted of uniform dispersion (PDI, 0.452 ​± ​0.03) of the nanometric globules (145.58 ​± ​12.5) of the dispersed phase, and negative surface charge (−21.1 ​± ​3.32 ​mV) with viscosity 297,600 ​cP and good spreadability. In vitro release of naringenin in phosphate buffer saline revealed a sustained release profile up to a maximum of 74.62 ​± ​4.54% from the formulated nanoemulgel (NG1) within the time-frame of 24 ​h. Alternatively, the release from the nanoemulsion was much higher (89.17 ​± ​2.87%), which might be due to lack of polymer coating on the dispersed oil droplets. Moreover, the in vitro release kinetics from the nanoemulgel followed the first-order release and Higuchi model with non-Fickian diffusion. Therefore, encouraging results in this research is evident in bringing a promising future in wound management, particularly associated with diabetes complications. Elsevier 2021-03-14 /pmc/articles/PMC8663980/ /pubmed/34909654 http://dx.doi.org/10.1016/j.crphar.2021.100019 Text en © 2021 Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Yeo, Eileen
Yew Chieng, Clement Jia
Choudhury, Hira
Pandey, Manisha
Gorain, Bapi
Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations
title Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations
title_full Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations
title_fullStr Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations
title_full_unstemmed Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations
title_short Tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: Fabrication, characterization and comparative in vitro evaluations
title_sort tocotrienols-rich naringenin nanoemulgel for the management of diabetic wound: fabrication, characterization and comparative in vitro evaluations
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663980/
https://www.ncbi.nlm.nih.gov/pubmed/34909654
http://dx.doi.org/10.1016/j.crphar.2021.100019
work_keys_str_mv AT yeoeileen tocotrienolsrichnaringeninnanoemulgelforthemanagementofdiabeticwoundfabricationcharacterizationandcomparativeinvitroevaluations
AT yewchiengclementjia tocotrienolsrichnaringeninnanoemulgelforthemanagementofdiabeticwoundfabricationcharacterizationandcomparativeinvitroevaluations
AT choudhuryhira tocotrienolsrichnaringeninnanoemulgelforthemanagementofdiabeticwoundfabricationcharacterizationandcomparativeinvitroevaluations
AT pandeymanisha tocotrienolsrichnaringeninnanoemulgelforthemanagementofdiabeticwoundfabricationcharacterizationandcomparativeinvitroevaluations
AT gorainbapi tocotrienolsrichnaringeninnanoemulgelforthemanagementofdiabeticwoundfabricationcharacterizationandcomparativeinvitroevaluations